MedTrace Logo

Superior Hypogastric Plexus Blockade in Laparoscopic Hysterectomy

NCT03427840 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2018-03-20

No results posted yet for this study

Summary

The primary indication for superior hypogastric plexus (SHP) block is visceral pelvic pain, most commonly from malignancy of the ovary, uterus, cervix, bladder, rectum or prostate. Per-cutaneous SHP blocks should be done under guidance of ultrasonography, fluoroscopy, magnetic resonance or computed tomography. During minimally invasive laparoscopic surgery, percutaneous technique can be done under the guidance of cameras.

Conditions

  • Superior Hypogastric Plexus Block
  • Hysterectomy
  • Minimally Invasive Surgery
  • Laparoscopy
  • Pain, Postoperative
  • Gynecologic Disease

Interventions

PROCEDURE

Procedure/Surgery: superior hypogastric block

superior hypogastric blockade during surgery

Sponsors & Collaborators

  • Derince Training and Research Hospital

    lead OTHER

Principal Investigators

  • Hande Aytuluk, MD · Derince Training and Research Hospital

  • Ahmet Kale, Prof · Derince Training and Research Hospital

  • Gulfem Basol, MD · Derince Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-18
Primary Completion
2018-06-30
Completion
2018-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03427840 on ClinicalTrials.gov